Clinical Trial Update: Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I study evaluating 5-fluorouracil in children and young adults with recurrent ependymoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Ependymoma

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Central Nervous System Malignancies, Ependymoma | Phase 1 | Status: COMPLETED